K111365 is an FDA 510(k) clearance for the VITALA CONTINENCE CONTROL DEVICE. Classified as Pouch, Colostomy (product code EZQ), Class I - General Controls.
Submitted by Convatec, Inc. (Skillman, US). The FDA issued a Cleared decision on August 19, 2011 after a review of 95 days - within the typical 510(k) review window.
This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.5900 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.
View all Convatec, Inc. devices
NCT01207479
Completed
Interventional
Industry-sponsored
Study to Assess the Safety and Performance of The VitalaTM Continence Control Device With Natura Moldable Skin Barriers
A Multi-Center, Open-Label, Feasibility Study to Assess the Safety and Performance of the VitalaTM Continence Control Device When Worn With SUR FIT Natura® Moldable TechnologyTM Skin Barrier Products Over a 12 Hour Period
| Condition studied |
Colostomy |
| Study design |
Single group |
| Eligibility |
All sexes
· 18 Years+
|
| Principal investigator |
Qing Li, PhD |
| Sponsor |
ConvaTec Inc.
(industry)
|
Started 2010-09-01
→
Primary completion 2010-11-01
Primary outcome
Assessment of Safety measured by the frequency of adverse events (AEs) relating to the stoma (including GI, and surrounding skin events) and stoma and peristomal vascularity.
Secondary outcome
Performance (Restoration of Continence)
Study completed - no results published.
This trial concluded in 2010 but has not posted
results to ClinicalTrials.gov. Completed studies without public results are common
in industry-sponsored device trials; the data may be referenced in the
510(k) Summary PDF or remain unpublished.
View full study on ClinicalTrials.gov